Zacks Investment Management’s Castle Biosciences CSTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-46,030	Closed	-$1.05M	–	656
2023 Q1	$1.05M	Buy	46,030 +3,541	+8%	+$80.5K	0.01%	356
2022 Q4	$1M	Buy	+42,489	New	+$1M	0.01%	360
2021 Q1	–	Sell	-14,673	Closed	-$985K	–	518
2020 Q4	$985K	Buy	+14,673	New	+$985K	0.02%	350